Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone

计划入组 2,256 人 · 首次发布于 2025 年 6 月 26 日

BRS and Outcomes in Cardiothoracic Surgery

计划入组 72 人 · 首次发布于 2017 年 8 月 8 日

SRDK0921_ Analytical Performance Study

计划入组 439 人 · 首次发布于 2023 年 2 月 28 日

Gene therapy(Janssen Global Services LLC)

Schizophrenia Therapeutics(Janssen Global Services LLC)

Cancer vaccine(Janssen Global Services LLC)

Boston Analytical, Inc.

United States

EMSL Analytical, Inc.

United States

Pace Analytical, Inc

United States

FDA Recalls Nearly 76,000 Cases of Eye Care Products Due to Manufacturing Deviations

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases